What is BIAF's dilution risk score?

BIAF has a latest available DilutionScore record of 82/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BIAF, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BIAF?

DilutionWatch tracks 25 SEC filing types for BIAF including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BIAF shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BIAF, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BIAF tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BIAF. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BIAF Dilution Risk Score: 82/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

85

📊 Float Risk

60

⚠️ Warrant Exposure

70

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 41%

📜 Warrant Exercise model 50%

• Massive warrant overhang: 35% of shares outstanding

• Elevated warrant risk score (70/100)

💰 Capital Raise model 35%

• Low cash runway: 3 months remaining

🔄 Reverse Split model est. 30%

• 52-week low $0.69 has breached $1

• Only 3 months cash — financial pressure

🔔 Track BIAF — Get forecast alerts →

Market Data

Market Cap$7.57M

Shares Outstanding8.10M

Float4.39M

Cash$2.43M

Debt$260.0K

Short InterestN/A

Institutional Holdings

QoQ: ↓ 93.6% shares (2026Q1 vs prior)

1 institutional holders · 3.2K shares

#1 BARCLAYS PLC 3.2K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest327.0K

Days to Cover1.5

% of Float7.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2022-12-31

8-K 8K EVENT 2026-04-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BIAF Dilution Snapshot

bioAffinity Technologies, Inc. (BIAF) has a DilutionScore of 82/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 2.8M.
Recent SEC activity tracked for BIAF: xbrl on 2026-06-30; 8-K on 2026-04-30; xbrl on 2022-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.